|
|
||||||||
European Journal of Cardio-Thoracic Surgery, Vol 9, 330-334, Copyright © 1995 by European Association for Cardio-thoracic Surgery
A Dodge, M Hurni, P Ruchat, F Stumpe, AP Fischer, G Van Melle and H Sadeghi
Seventy-nine patients (mean age 49 years) underwent valve replacement or
repair for active (58.2%) or healed (41.8%) native valve endocarditis
between 1976 and 1992. The most common indication for surgery was
congestive heart failure (73.4%), followed by multiple systemic emboli
(21.5%). Emergency operation was necessary in 27.8% of the cases. Operative
mortality was 3.8% (3 patients) and late mortality 15.1% (12 patients).
Streptococci were the most common infecting agents (41.8%), followed by
Staphylococcus aureus (11.4%). No organisms were isolated in 27 cases
(34.2%). Follow-up spanned 379.8 patient-years with a maximum of 15.8
years. Fifteen late valve-related events (periprosthetic leak, recurrent
endocarditis, thrombo-embolic events and hemolysis) and 20 other late
complications (anticoagulant-related hemorrhage, arrhythmias or congestive
heart failure) occurred in 22 patients. The linearized rate for all late
complications is 5.8% per patient-year. The influence of eight preoperative
variables on overall mortality and late valve-related complications was
assessed: age, valve(s) affected, active or healed infection, bacteriology,
annular abscess, emergency or elective surgery, preoperative renal function
and NYHA class. Only Staphylococcus aureus (P = 0.0012) was a significant
predictor of late valve-related complications. Furthermore, no difference
in survival or in valve-related complications was found between the active
and healed infections.
ARTICLES
Surgery in native valve endocarditis: indications, results and risk factors
Department of Cardiovascular Surgery, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
This article has been cited by other articles:
![]() |
A. Colli, R. Campodonico, and T. Gherli Early Switch From Vancomycin to Oral Linezolid for Treatment of Gram-Positive Heart Valve Endocarditis Ann. Thorac. Surg., July 1, 2007; 84(1): 87 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Murashita, H. Sugiki, Y. Kamikubo, and K. Yasuda Surgical results for active endocarditis with prosthetic valve replacement: impact of culture-negative endocarditis on early and late outcomes Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1104 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Mistiaen, Ph. Van Cauwelaert, Ph. Muylaert, S. U. Sys, F. Harrisson, and H. Bortier Thromboembolic events after aortic valve replacement in elderly patients with a Carpentier-Edwards Perimount pericardial bioprosthesis J. Thorac. Cardiovasc. Surg., April 1, 2004; 127(4): 1166 - 1170. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Guerra, M P Tornos, G Permanyer-Miralda, B Almirante, M Murtra, and J Soler-Soler Long term results of mechanical prostheses for treatment of active infective endocarditis Heart, July 1, 2001; 86(1): 63 - 68. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, S. M. Langley, H. Stafford, J. A. Lowes, S. A. Livesey, and J. L. Monro Surgery for active culture-positive endocarditis: determinants of early and late outcome Ann. Thorac. Surg., May 1, 2000; 69(5): 1448 - 1454. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ruchat, M. Hurni, A. P. Fischer, and H. Sadeghi Semicontinuous Suture Technique for All Prosthetic Valve Insertions: The "Hoist" Technique Ann. Thorac. Surg., March 1, 1998; 65(3): 859 - 860. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |